Immunosuppression: Clinical Trials

1 trial for Immunosuppression, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Terminated 1
Phase 21Terminated 1

Follow Immunosuppression: new trials by email Literature Review of Immunosuppression trials Research Report on Immunosuppression

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
High-Dose Moderna mRNA-1273 Booster Study for Lung Transplant Recipients
mRNA-1273 (Moderna COVID-19 vaccine) - Lung Transplant Recipient, SARS-CoV-2
Phase 1 / Phase 2TerminatedUniversity of California, Los Angeles192022-03-102025-03-26

Interventions

2019-nCoV Vaccine mRNA-1273 (1)

Sponsors

University of California, Los Angeles (1)

Countries

United States (1)

Top investigators

Yusaku Michael Shino, MD (1)